SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-009661
Filing Date
2024-02-02
Accepted
2024-02-02 06:02:48
Documents
14
Period of Report
2024-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244907d1_8k.htm   iXBRL 8-K 26133
  Complete submission text file 0001104659-24-009661.txt   199089

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20240131.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20240131_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20240131_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT tm244907d1_8k_htm.xml XML 3594
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 24588689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)